Literature DB >> 29517711

Incidence and Risk Factors of Intrauterine Transmission Among Pregnant Women With Chronic Hepatitis B Virus Infection.

Songxu Peng1, Zhihua Wan1, Tingting Liu1, Huiping Zhu2, Yukai Du1.   

Abstract

GOALS: To identify the potential risk factors of hepatitis B virus (HBV) intrauterine transmission and predict the incidence of HBV intrauterine transmission among hepatitis B surface antigen-positive pregnant women with diverse viral load.
BACKGROUND: The intrauterine transmission of HBV significantly contributes to the persistence of a high number of patients infected with HBV. However, its risk factors remain unclear.
MATERIALS AND METHODS: A prospective study was performed on hepatitis B surface antigen-positive pregnant women who delivered from June 2012 to December 2016 at Wuhan Medical Care Center for Women and Children, Wuhan, China.
RESULTS: In total, 1200 women paired with 1219 infants were enrolled. In total, 11 (0.9%) infants were identified with intrauterine transmission. We observed that all infants with intrauterine transmission were born to hepatitis B e antigen-positive mothers who had serum HBV DNA levels >7 log10 copies/mL. Our study suggested that the HBV DNA levels (for each log10 copies/mL increase, odds ratio=5.43; 95% confidence interval, 1.31-22.43; P=0.019) had independent effects on HBV intrauterine transmission in a multivariate logistic regression model. Moreover, cesarean section (odds ratio=0.18; 95% confidence interval, 0.04-0.74; P=0.018) was associated with a reduced risk of HBV intrauterine transmission. The predictive rates of intrauterine transmission were 0.06%, 0.50%, 2.81%, 8.89% in infants with maternal HBV DNA levels of 10, 10, 10, 10 copies/mL, respectively.
CONCLUSIONS: Our data confirmed that increasing maternal viral load has the ability to predict intrauterine HBV transmission. Vaginal delivery increased risk of HBV transmission in infants compared with cesarean section. Further studies are warranted to clarify the possible mechanism underlying these associations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29517711     DOI: 10.1097/MCG.0000000000001001

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers.

Authors:  Wenjun Zhang; Chenyu Xu; Yanjing Rui; Jie Chen; Tingmei Chen; Yimin Dai; Biyun Xu; Yali Hu; Junhao Chen; Yi-Hua Zhou
Journal:  J Virus Erad       Date:  2022-06-20

Review 2.  Host Genetic Determinants of Hepatitis B Virus Infection.

Authors:  Zhenhua Zhang; Changtai Wang; Zhongping Liu; Guizhou Zou; Jun Li; Mengji Lu
Journal:  Front Genet       Date:  2019-08-13       Impact factor: 4.599

3.  Expanding Antiviral Prophylaxis During Pregnancy to Prevent Perinatal Hepatitis B Virus Infection: A Cost-effectiveness Study.

Authors:  Jiangyang Du; Zhenhua Wang; Bin Wu
Journal:  Open Forum Infect Dis       Date:  2020-04-21       Impact factor: 3.835

4.  Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study.

Authors:  Zhenhua Li; Xuefei Duan; Yuhong Hu; Mingfang Zhou; Min Liu; Kai Kang; Haodong Cai; Wei Yi; Dong Fu; Xuesong Gao
Journal:  Biomed Res Int       Date:  2020-04-27       Impact factor: 3.411

5.  Therapeutic effect of erythropoietin on brain injury in premature mice with intrauterine infection.

Authors:  Hongxue Liu; Muling Zhang; Xiao Han
Journal:  Saudi J Biol Sci       Date:  2020-06-01       Impact factor: 4.219

6.  Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.

Authors:  Ying Lu; Yarong Song; Xiangjun Zhai; Fengcai Zhu; Jianxun Liu; Zhanjun Chang; Yi Li; Yiwei Xiao; Lili Li; Minmin Liu; Jia Liu; Zhongping Duan; Huaibin Zou; Hui Zhuang; Jie Wang; Jie Li
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

7.  The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B.

Authors:  Maito Suoh; Akihiro Tamori; Yuga Amano-Teranishi; Takashi Nakai; Masaru Enomoto; Yasuko Kawasaki; Kiyohide Kioka; Norifumi Kawada
Journal:  Intern Med       Date:  2020-01-15       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.